429 related articles for article (PubMed ID: 17044203)
1. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant tuberculosis in Yangon, Myanmar.
Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
4. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
5. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Bai GH; Park YK; Choi YW; Bai JI; Kim HJ; Chang CL; Lee JK; Kim SJ
Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of drug resistance in pulmonary tuberculosis patients at Sureyyapasa Chest Diseases Hospital, Istanbul, Turkey.
Karagoz T; Pazarli P; Mocin OY; Duman D; Duman G; Salturk C; Unal O
Int J Tuberc Lung Dis; 2008 Jun; 12(6):631-5. PubMed ID: 18492329
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
LoBue PA; Moser KS
Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
[TBL] [Abstract][Full Text] [Related]
8. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
[TBL] [Abstract][Full Text] [Related]
9. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
Aung WW; Ti T; Than KK; Thida M; Nyein MM; Htun YY; Maung W; Htun A
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):104-10. PubMed ID: 17539254
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002.
Dewan P; Sosnovskaja A; Thomsen V; Cicenaite J; Laserson K; Johansen I; Davidaviciene E; Wells C
Int J Tuberc Lung Dis; 2005 Feb; 9(2):170-4. PubMed ID: 15732736
[TBL] [Abstract][Full Text] [Related]
11. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
12. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
14. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
16. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
17. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan.
Javaid A; Hasan R; Zafar A; Ghafoor A; Pathan AJ; Rab A; Sadiq A; Akram CM; Burki I; Shah K; Ansari M; Rizvi N; Khan SU; Awan SR; Syed ZA; Iqbal ZH; Shaheen Z; ur Rehman N
Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840
[TBL] [Abstract][Full Text] [Related]
19. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
